< Back to previous page
Researcher
Marc Van Ranst
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 2005 → 31 Dec 2006 - Laboratory of Clinical and Epidemiological Virology (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 29
- Environmental sampling as a tool to monitor enteric virus epidemiologyFrom1 Feb 2023 → TodayFunding: FWO fellowships
- SDS/EDTA-treated chromatography paper strips for laboratory confirmation of monkeypox virus in the context of the global mpox epidemiologyFrom2 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The assessment of virome composition and dynamic in blood transfusion settingFrom1 Oct 2020 → TodayFunding: BOF - projects
- Development of a new point-of-care COVID-19 screening using exhaled-breath volatilome analysis.From1 Apr 2020 → 31 Mar 2021Funding: IOF - technology validation in lab
- Microbial Communities in Biomedical and Environmental Areas, and Systems BiologyFrom1 Jan 2018 → 31 Aug 2021Funding: H2020-EU.4. - Spreading excellence and widening participation
- Third generation sequencing and herpesvirus diversity: Towards complete double-stranded DNA virus genomesFrom8 Dec 2017 → 20 Dec 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Metagenomic analysis of the virome of the honeybee (Apis mellifera) in the Czech RepublicFrom1 Oct 2017 → 30 Sep 2019Funding: BOF - Bilateral scientific cooperation
- Rotavirus in Bats and Humans: Genetic Diversity and Gastroenteritis in the Post-Vaccine EraFrom1 Oct 2017 → 25 Jan 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Host switching pathogens, infectious outbreaks and zoonosis; a Marie Sklodowska-Curie Training NetworkFrom1 Apr 2017 → 31 Mar 2021Funding: H2020 - Skills and Career Development (Marie Skłodowska-Curie) actions
- Development and application of filovirus reverse genetics systems for antiviral compound screeningFrom1 Jan 2017 → 24 Sep 2021Funding: FWO Strategic Basic Research Grant
Publications
301 - 310 of 362
- RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy(2009)
Authors: Marc Van Ranst
Pages: 3952 - 3962 - Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice(2009)
Authors: Els Keyaerts, Sandra Li, Evelien Rysman, Jannick Verbeeck, Marc Van Ranst, Piet Maes
Pages: 3416 - 3421 - Replication reduction neutralization test, a quantitative RT-PCR-based technique for the detection of neutralizing hantavirus antibodies(2009)
Authors: Piet Maes, Els Keyaerts, Sandra Li, Jan Clement, Marc Van Ranst
Pages: 295 - 299 - Evaluation of the New Architect Cytomegalovirus Immunoglobulin M (IgM), IgG, and IgG Avidity Assays(2009)
Authors: Katrien Lagrou, Marc Van Ranst
Pages: 1695 - 1699 - Rolling-circle amplification of viral DNA genomes using phi29 polymerase(2009)
Authors: Annabel Rector, Marc Van Ranst, Hans Stevens
Pages: 205 - 211 - Are Human P[14] Rotavirus Strains the Result of Interspecies Transmissions from Sheep or Other Ungulates That Belong to the Mammalian Order Artiodactyla?(2009)
Authors: Jelle Matthijnssens, Mark Zeller, Marc Van Ranst
Pages: 2917 - 2929 - Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infection(2009)
Authors: Frederik Nevens, Marc Van Ranst, Frank Buntinx
Pages: 589 - 94 - An outbreak of hepatitis A associated with the consumption of raw beef(2009)
Authors: Jannick Verbeeck, Marc Van Ranst
Pages: 207 - 210 - Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples(2009)
Authors: Veerle Cossey, Marc Van Ranst, Myriam Hanssens, Katrien Lagrou
Pages: 660 - 665 - Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis(2009)
Authors: Marc Van Ranst, Marc Aerts